Yoshihiro Otaki
Presidente en BioFrontier Partners, Inc. .
Perfil
Yoshihiro Otaki is the founder of Human Metabolome Technologies, Inc. which was founded in 2003.
He held the title of Chairman from 2003 to 2011.
He is currently the Chairman and Representative Director at Healthcare Innovation Co. Ltd.
He is also an Outside Director at GeneCare Research Institute Co., Ltd.
since 2000, a Director at Cell-Medicine, Inc., and the President of BioFrontier Partners, Inc. since 1999.
Dr. Otaki received his doctorate degree from Tohoku University in 1979 and his undergraduate degree from the same university in 1973.
Cargos activos de Yoshihiro Otaki
| Empresas | Cargo | Inicio |
|---|---|---|
BioFrontier Partners, Inc.
 BioFrontier Partners, Inc. Investment ManagersFinance BioFrontier Partners Inc (BioFrontier Partners) is a venture capital firm founded in 2000. The firm is headquartered in Tokyo, Japan. | Presidente | 10/03/1999 |
GeneCare Research Institute Co., Ltd.
 GeneCare Research Institute Co., Ltd. Medical/Nursing ServicesHealth Services GeneCare Research Institute Co., Ltd. engages in the research, development, and drug discovery of treatments in the field of cancer, inflammation, hepatic carcinoma and rheumatism. It provides the distribution services for its products through their direct customers, which includes pharmaceutical companies and clinical-related companies. The company was founded by Yasuhiro Furuichi on December 20, 2000 and is headquartered in Kamakura, Japan. | Director/Miembro de la Junta | 20/12/2000 |
Healthcare Innovation Co. Ltd.
 Healthcare Innovation Co. Ltd. Investment ManagersFinance Healthcare Innovation Co. Ltd. (Healthcare Innovation) is a Venture Capital firm founded in 2017. The firm is headquartered in Tokyo, Japan. | Presidente | - |
Cell-Medicine, Inc.
 Cell-Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cell-Medicine, Inc. is a Japanese company that specializes in cancer immunotherapy based on scientific evidence. The private company is based in Tsukuba, Japan. The company aims to prevent the recurrence of cancer after surgery, prevent metastasis, and treat remaining cancer. The company's self-cancer vaccine therapy is based on scientific evidence and is designed to target recurring and metastasizing cancer after surgery, as well as treat remaining cancer. The company was founded in 2001 by Tadao Ono. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Yoshihiro Otaki.
| Empresas | Cargo | Fin |
|---|---|---|
| HUMAN METABOLOME TECHNOLOGIES, INC. | Fundador | - |
Formación de Yoshihiro Otaki.
| Tohoku University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| HUMAN METABOLOME TECHNOLOGIES, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
BioFrontier Partners, Inc.
BioFrontier Partners, Inc. Investment ManagersFinance BioFrontier Partners Inc (BioFrontier Partners) is a venture capital firm founded in 2000. The firm is headquartered in Tokyo, Japan. | Finance |
GeneCare Research Institute Co., Ltd.
GeneCare Research Institute Co., Ltd. Medical/Nursing ServicesHealth Services GeneCare Research Institute Co., Ltd. engages in the research, development, and drug discovery of treatments in the field of cancer, inflammation, hepatic carcinoma and rheumatism. It provides the distribution services for its products through their direct customers, which includes pharmaceutical companies and clinical-related companies. The company was founded by Yasuhiro Furuichi on December 20, 2000 and is headquartered in Kamakura, Japan. | Health Services |
Healthcare Innovation Co. Ltd.
Healthcare Innovation Co. Ltd. Investment ManagersFinance Healthcare Innovation Co. Ltd. (Healthcare Innovation) is a Venture Capital firm founded in 2017. The firm is headquartered in Tokyo, Japan. | Finance |
Cell-Medicine, Inc.
Cell-Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cell-Medicine, Inc. is a Japanese company that specializes in cancer immunotherapy based on scientific evidence. The private company is based in Tsukuba, Japan. The company aims to prevent the recurrence of cancer after surgery, prevent metastasis, and treat remaining cancer. The company's self-cancer vaccine therapy is based on scientific evidence and is designed to target recurring and metastasizing cancer after surgery, as well as treat remaining cancer. The company was founded in 2001 by Tadao Ono. | Health Technology |
- Bolsa de valores
- Insiders
- Yoshihiro Otaki
